These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pathophysiologic mechanisms and management of neutropenia associated with large granular lymphocytic leukemia. Pontikoglou C; Kalpadakis C; Papadaki HA Expert Rev Hematol; 2011 Jun; 4(3):317-28. PubMed ID: 21668396 [TBL] [Abstract][Full Text] [Related]
5. T cell large granular lymphocyte leukemia associated with rheumatoid arthritis and neutropenia. Shah A; Diehl LF; St Clair EW Clin Immunol; 2009 Aug; 132(2):145-52. PubMed ID: 19394280 [TBL] [Abstract][Full Text] [Related]
13. Advances in the Diagnosis and Treatment of Large Granular Lymphocytic Leukemia. Cheon H; Dziewulska KH; Moosic KB; Olson KC; Gru AA; Feith DJ; Loughran TP Curr Hematol Malig Rep; 2020 Apr; 15(2):103-112. PubMed ID: 32062772 [TBL] [Abstract][Full Text] [Related]
14. Network model of survival signaling in large granular lymphocyte leukemia. Zhang R; Shah MV; Yang J; Nyland SB; Liu X; Yun JK; Albert R; Loughran TP Proc Natl Acad Sci U S A; 2008 Oct; 105(42):16308-13. PubMed ID: 18852469 [TBL] [Abstract][Full Text] [Related]
15. Advances in diagnosis and treatment of large granular lymphocyte syndrome. Prochorec-Sobieszek M Curr Opin Hematol; 2011 Jan; 18(1):55-62. PubMed ID: 20975557 [TBL] [Abstract][Full Text] [Related]
16. Molecular Features and Diagnostic Challenges in Alpha/Beta T-Cell Large Granular Lymphocyte Leukemia. Gaudio F; Masciopinto P; Bellitti E; Musto P; Arcuti E; Battisti O; Cazzato G; Solombrino A; Laddaga FE; Specchia G; Maiorano E; Ingravallo G Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362180 [TBL] [Abstract][Full Text] [Related]
17. T-Cell Large Granular Lymphocyte Leukemia in a Patient With Rheumatoid Arthritis. Naji Rad S; Rafiee B; Raju G; Solhjoo M; Anand P J Investig Med High Impact Case Rep; 2020; 8():2324709620941303. PubMed ID: 32646239 [TBL] [Abstract][Full Text] [Related]
18. Cell size variations of large granular lymphocyte leukemia: Implication of a small cell subtype of granular lymphocyte leukemia with STAT3 mutations. Tanahashi T; Sekiguchi N; Matsuda K; Takezawa Y; Ito T; Kobayashi H; Ichikawa N; Nishina S; Senoo N; Sakai H; Nakazawa H; Ishida F Leuk Res; 2016 Jun; 45():8-13. PubMed ID: 27064362 [TBL] [Abstract][Full Text] [Related]
19. Familial CD3+ T large granular lymphocyte leukemia: evidence that genetic predisposition and antigen selection promote clonal cytotoxic T-cell responses. Stalika E; Papalexandri A; Iskas M; Stavroyianni N; Kanellis G; Kotta K; Pontikoglou C; Siorenta A; Anagnostopoulos A; Papadaki H; Papadaki T; Stamatopoulos K Leuk Lymphoma; 2014 Aug; 55(8):1781-7. PubMed ID: 24180333 [TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive therapy of LGL leukemia: prospective multicenter phase II study by the Eastern Cooperative Oncology Group (E5998). Loughran TP; Zickl L; Olson TL; Wang V; Zhang D; Rajala HL; Hasanali Z; Bennett JM; Lazarus HM; Litzow MR; Evens AM; Mustjoki S; Tallman MS Leukemia; 2015 Apr; 29(4):886-94. PubMed ID: 25306898 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]